Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM-POWR Study.
European journal of haematology
View this publicationEuropean journal of haematology
View this publicationHematology (Amsterdam, Netherlands)
View this publicationFrontiers in immunology
View this publicationThe New England journal of medicine
View this publicationBMC palliative care
View this publicationGenes
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationJournal of the American College of Cardiology
View this publicationScience immunology
View this publicationJournal of Alzheimer's disease : JAD
View this publication